DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Cardiology Homepage

NIH grants over $1 million to development of non-contrast imaging approaches Will be used to diagnose peripheral arterial disease

Elsevier touts new study validating use of STATdx solution Reduced diagnostic errors by as much as 37 percent

Pre-activating cardiac catherization labs benefits EMS STEMI patients on arrival Saves critical minutes and can bypass typical ED protocols

Apple Watch can monitor heart rhythms with FDA approval Detects atrial fibrillation and can tell if you've taken a sudden fall

Keith D. Dawkins InnovHeart elects chairman of the board

Jeffrey S. Brown Endologix appoints chief operations officer

Bioengineers create virtual 3D heart with AI Could provide a boost to the treatment of atrial fibrillation

Fractional flow reserve CT can reduce invasive heart procedures: study First clinical study on benefits of FFRCT for moderate stenosis

Philips unveils new ultrasounds for general and interventional cardiology Equipped with anatomical intelligence

MaxQ-AI seeks $8 million public IPO listing on Nasdaq Will help FDA regulatory processes for Accipio software products

FDA greenlights Neural Analytics' NeuralBot System

by John R. Fischer , Staff Reporter
Using blood flow in the brain to assess the risk of stroke may now be more accessible following FDA clearance for Neural Analytics Inc.’s NeuralBot System.

Combined with the Lucid M1 Transcranial Doppler Ultrasound system, the robotic assistance solution enables healthcare professionals in the company of a neurologist to noninvasively evaluate changes in blood flow and emboli, and the reaction of brain tissue to these changes, to assess stroke or detect the risk of it and other neurological conditions.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

“A patient may show up at a hospital and be recommended to receive a transcranial doppler ultrasound,” Robert Hamilton, co-founder and chief scientific officer at Neural Analytics, told HCB News. “Unfortunately, the expert technician may no longer be there or the hospital doesn’t provide coverage. The use of the Neuralbot system allows for a healthcare professional, accompanied by a neurologist who can read the information, to perform and get that information without the need for an expert stenographer.”

Incorrect assessments of large vessel stroke often lead to misdiagnoses and treatment delays, which heighten the chances of death or disability. Many of these cases are due to the lack of available low-cost and objective patient diagnostic information, and can burden patients with additional healthcare expenditures.

Equipped with system review, spectrogram editing and PDF reporting, the Lucid M1 TCD System processes a doppler signal in twice the resolution of legacy equipment and offers a platform for analysis of the complete waveform spectrum.

The Neuralbot System pairs with the Lucid M1 Transcranial Doppler Ultrasound to form the Lucid Robotic system which acts as an advanced probe for neurological assessment by assisting in the set up and acquisition of the data that is collected on the Lucid system. Neuralbot enables automatic adjustment in orientation and position of the ultrasound product under the guidance of a healthcare professional.

Information is then interpreted by a clinician for diagnosis, treatment or changes in management. A recent evaluation found no difference in the use of the Neuralbot System for assessing blood flow data, compared to manual collection by an expert technician with a traditional ultrasound platform.

Hamilton says the dual combination of both technologies provides neurologists with additional information they may not have and enables greater access to necessary care for patients with neurological conditions.

“Just increasing access to this technology gives them the ability to perform these measures when they need to, allowing them to have that information to provide the clinical care that the guidance calls for,” he said.

More than 795,000 people suffer strokes in the U.S., with one occurring every 40 seconds and killing a person every four minutes. Such events, along with traumatic brain injury, migraine, and Alzheimer's account for more than $438 billion of the $800 billion incurred by the U.S. healthcare system annually due to neurological disorders.

The Neuralbot system will be made available with the Lucid M1 TCD system which is also FDA cleared. The Lucid Robotic system is reimbursable by Medicare, Medicaid and most private payers.

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.